2016

Researcher Pandolfi outlines promising paths for cures, including targeted therapy, RNA medicine, and immune therapy By Alvin Powell, Harvard Staff Writer In recent years, cancer patients have benefited from a new array of weapons to fight the disease...

Immature (undifferentiated) cells are on the left panel and cells that have differentiated in response to treatment with brequinar are on the right panel. Photo courtesy of Scadden Lab. Simple compound could provide first new therapy for AML in four...

Zika virus (light blue) spreads through a three-dimensional model of a developing brain. Image courtesy of Max Salick and Nathaniel Kirkpatrick/Novartis The fast-spreading virus can take multiple routes into developing human nerve cells. By Hannah Robbins...

HSCI codirector David Scadden has been named a Fellow of the American Association for the Advancement of Science (AAAS). This year 391 members have been awarded this honor by AAAS because of their scientifically or socially distinguished efforts to...

Photo courtesy of Vionnie Yu, Scadden Lab. Color-labeling helps Harvard researchers track the development and behavior of individual cells By Hannah Robbins Harvard Stem Cell Institute (HSCI) researchers have used a colorful, cell-labeling technique to...

Startup Magenta Therapeutics licences technologies from Harvard, MGH, and Boston Children's that could transform treatment of blood diseases and immune disorders Harvard University has completed a license agreement with Magenta Therapeutics, a new startup...

The Harvard Stem Cell Institute (HSCI) is pleased to announce the success of the 2015–16 General Fund Matching Challenge. Throughout fiscal year 2016, HSCI saw an outpouring of unrestricted funding, resulting in $2.6 million in new gifts and pledges. This...

Tongue-on-a-chip provides insight into genetic diseases By Leah Burrows, SEAS Science and Technology Communications Officer Muscular dystrophy is a group of rare genetic diseases that cause progressive muscle weakness and deterioration. For decades...

In a flask of clear, pale yellow liquid, 300-400 million beta cells, the insulin-producing cells attacked or defective in diabetics, swirl in a cocktail of cell food and Stage 6 medium. Ten years ago, researchers were still working on protocols to turn...